Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies.

However, this came at the expense of overall and long-term reduced CAR expression and increased PD-L1 levels indicating exhaustion, and the observed survival benefit did not reach statistical significance.

also in 111,027 other papers